Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
 
Program Contents
bullet Programs
Contact Info

English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760

International Travel
Phone: 1-887-394-8747
Contact CDC-INFO

Keep your kids healthy. cdc.gov/parents
 

Diarrheagenic Escherichia coli
(non-Shiga toxin-producing E. coli)

Disease Listing | General Information | Technical Information | Additional Information

Clinical Features Watery or bloody diarrhea, abdominal cramps, with or without fever.
Etiologic Agent Escherichia coli of many different serotypes, categorized into four major groups according to virulence mechanisms: enterotoxigenic (ETEC); enteropathogenic (EPEC); enteroinvasive (EIEC); and enteroaggregative (EAgg EC). Other groups (e.g., diffusely adherent E. coli) are less well established as pathogens.
Incidence Unknown; very few laboratories can identify these organisms. Enterotoxigenic E. coli are the most common cause of travelers' diarrhea and have caused several foodborne outbreaks in the United States. There are an estimated 79,420 cases of ETEC in the United States each year. EPEC and EIEC primarily infect children in the developing world. Enteroaggregative E. coli probably cause chronic diarrhea in HIV-infected patients.
Sequelae Sequelae of ETEC, EPEC, and EIEC infection are not well described. Enteroaggregative E. coli may cause chronic diarrhea.
Transmission Through food or water contaminated with human or animal feces. Person-to-person transmission may also occur, but is likely to be less common.
Risk Groups International travelers are at greatest risk for ETEC infection, while EPEC and EIEC are most common among young children in the developing world. EAggEC are most common among immunocompromised persons.
Surveillance There is no formal surveillance system for diarrheogenic E. coli and most laboratories are unable to identify them.
Trends Apparent steady increase in domestic ETEC outbreaks. ETEC are increasingly resistant to available antimicrobial agents, and this is likely true for EPEC, EIEC, and EAggEC as well.
Challenges Improve surveillance by transferring the techniques for identification and serotyping diarrheogenic E. coli to public health and clinical laboratories. Better understand the molecular genetics of the diverse virulence mechanisms of these organisms and thereby develop tools to enable more rapid detection of emerging diarrheogenic E. coli strains.
Opportunities Improve surveillance of new and emerging diarrheogenic E. coli strains through studies of sporadic or outbreak-associated cases of diarrhea of unknown etiology. Measure the effect of non-vaccine interventions to prevent diarrheal disease on the incidence of infections caused by diarrheogenic E. coli through collaborative intervention studies.
 
 
Date: October 6, 2005
Content source: National Center for Immunization and Respiratory Diseases: Division of Bacterial Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
English and Spanish: (800) CDC-INFO / (800) 232-4636
TTY: (888) 232-6348 / FAX: (770) 488-4760